Interaction Propensity
Strongest directed Tier 1 cell-ontology contact preference per sample. Bulk files are centralized on the Download page.
51-100 of 2,070
Interaction Propensity
Strongest directed Tier 1 cell-ontology contact preference per sample.
2,069 ready
| Sample | Organ | Disease state | Cells | Strongest directed pair ?Tier 1 from-label to to-label pair with the largest departure from neutral propensity among enriched/depleted contacts. | Direction | Propensity | FDR |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_A4,1 | Lung | Primary cancer | 3,135 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.51 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A4,10 | Lung | Primary cancer | 3,642 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.56 | 9.90e-3 |
| NSCLC_38242124__IMC__175_A4,11 | Lung | Primary cancer | 2,707 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.38 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A4,12 | Lung | Primary cancer | 2,297 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.93 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A4,13 | Lung | Primary cancer | 5,499 | Stromal -> Stromal | Enriched | 4.94 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A4,14 | Lung | Primary cancer | 2,772 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.45 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A4,15 | Lung | Primary cancer | 2,740 | Stromal -> Stromal | Enriched | 4.00 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A4,16 | Lung | Primary cancer | 2,936 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.42 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A4,17 | Lung | Primary cancer | 4,066 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.20 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A4,2 | Lung | Primary cancer | 1,512 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.64 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A4,3 | Lung | Primary cancer | 2,042 | Stromal -> Stromal | Enriched | 3.68 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A4,4 | Lung | Primary cancer | 2,380 | Immune -> Immune | Enriched | 3.38 | 1.76e-2 |
| NSCLC_38242124__IMC__175_A4,5 | Lung | Primary cancer | 1,974 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.88 | 9.90e-3 |
| NSCLC_38242124__IMC__175_A4,6 | Lung | Primary cancer | 2,673 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.25 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A4,7 | Lung | Primary cancer | 1,491 | Immune -> Immune | Enriched | 3.25 | 2.26e-2 |
| NSCLC_38242124__IMC__175_A4,8 | Lung | Primary cancer | 1,550 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.01 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A4,9 | Lung | Primary cancer | 3,457 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.24 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A5,1 | Lung | Primary cancer | 4,373 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.75 | 9.90e-3 |
| NSCLC_38242124__IMC__175_A5,10 | Lung | Primary cancer | 3,202 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.89 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A5,11 | Lung | Primary cancer | 2,764 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.59 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A5,12 | Lung | Primary cancer | 3,952 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.60 | 1.58e-2 |
| NSCLC_38242124__IMC__175_A5,13 | Lung | Primary cancer | 4,010 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.02 | 9.90e-3 |
| NSCLC_38242124__IMC__175_A5,14 | Lung | Primary cancer | 4,271 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.88 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A5,15 | Lung | Primary cancer | 2,937 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.03 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A5,16 | Lung | Primary cancer | 3,132 | Stromal -> Stromal | Enriched | 4.94 | 1.58e-2 |
| NSCLC_38242124__IMC__175_A5,17 | Lung | Primary cancer | 2,717 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.54 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A5,2 | Lung | Primary cancer | 1,924 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.90 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A5,3 | Lung | Primary cancer | 1,476 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.75 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A5,4 | Lung | Primary cancer | 3,742 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.66 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A5,5 | Lung | Primary cancer | 3,255 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.05 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A5,6 | Lung | Primary cancer | 2,342 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.51 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A5,7 | Lung | Primary cancer | 2,320 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.35 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A5,9 | Lung | Primary cancer | 3,778 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.48 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A6,1 | Lung | Primary cancer | 4,537 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.02 | 9.90e-3 |
| NSCLC_38242124__IMC__175_A6,10 | Lung | Primary cancer | 2,854 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.90 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A6,11 | Lung | Primary cancer | 2,675 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.09 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A6,12 | Lung | Primary cancer | 3,218 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.29 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A6,13 | Lung | Primary cancer | 2,913 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.85 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A6,14 | Lung | Primary cancer | 4,124 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.50 | 9.90e-3 |
| NSCLC_38242124__IMC__175_A6,15 | Lung | Primary cancer | 3,501 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.77 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A6,16 | Lung | Primary cancer | 2,655 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.24 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A6,2 | Lung | Primary cancer | 1,655 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.79 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A6,3 | Lung | Primary cancer | 2,958 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.82 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A6,4 | Lung | Primary cancer | 3,632 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.07 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A6,5 | Lung | Primary cancer | 3,151 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.11 | 9.90e-3 |
| NSCLC_38242124__IMC__175_A6,6 | Lung | Primary cancer | 3,540 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.98 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A6,7 | Lung | Primary cancer | 1,620 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.54 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A6,8 | Lung | Primary cancer | 2,924 | Stromal -> Stromal | Enriched | 4.33 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A6,9 | Lung | Primary cancer | 3,563 | Stromal -> Stromal | Enriched | 3.92 | 1.58e-2 |
| NSCLC_38242124__IMC__175_A7,1 | Lung | Primary cancer | 3,312 | Immune -> Immune | Enriched | 3.78 | 1.58e-2 |